7
Views
1
CrossRef citations to date
0
Altmetric
Original Paper

A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs

, , , , , , & show all
Pages 349-361 | Published online: 07 Jul 2009

References

  • Wagner JE, Rosenthal J, Sweetman R et al. Successful trans-plantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795–802.
  • Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl y Med 2001;344:1815–22.
  • Cairo MS, Wagner JE. Placental and/or umbilical cord blood: analternative source of hematopoietic stem cells for transplanta-tion. Blood 1997;90:4665— 78.
  • Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors [see comments]. N Engl 7 Med 1998;339:1565— 77.
  • Abu-Ghosh A, Goldman S, Slone V et al. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft- versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Bone Marrow Transplant 1999;24:535–44.
  • Cairo M, Suen Y, Knoppel E, et al. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared to adults. Pediatr Res 1991;30:362— 7.
  • Cairo MS, Suen Y, Knoppel E, et al. Decreased G-CSF and IL-3production and gene expression from mononuclear cells of newborn infants. Pediatr Res 1992;31:574–8.
  • Qlan JX, Lee SM, Suen Y et al. Decreased interleukin-15 fromactivated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997;90:3106— 17.
  • Lee SM, Suen Y, Chang L et al. interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL- 12 in cord blood mononuclear cells. Blood 1996;88:945— 54.
  • Suen Y, Lee SM, Schreurs J et al. Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered posttranscriptional stability. Blood 1994;84:4269–77.
  • Wu J, Cairo S, van de Yen C et al. Significant downregulation ofInterleukin (IL-)-18 gene expression and protein production in constitutive and activated umbilical cord blood (CB) vs adult peripheral blood (APB) mononuclear cells (MNC): Potential mechanism for differential alloreactivity. Blood 2001;98:205a.
  • Bracho F', Goldman S, Cairo MS. Potential use of granulocyte colony-stimulating factor and granulocyte- macrophage colony-stimulating factor in neonates. Curr Opin Hematol 1998;5:215–20.
  • Gaddy J, Risdon G, Broxmeyer HE. blood natural killer cells arefunctionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. 7 Interferon Cytokine Res 1995;15: 527–36.
  • Cohen SB, Dominiguez E, Lowdell M, Madrigal JA. immuno-logical properties of cord blood: overview of current research presented at the 2nd EUROCORD workshop. Bone Marrow Transplant 1998;22 (Suppl 1):522–5.
  • Miyagawa Y, Sugita K, Komiyama A, Akabane T Delayed in vitro immunoglobulin production by cord lymphocytes. Pedia-trics 1980;65:497–500.
  • Banchereau J, Briere F', Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767–811.
  • Steinman R, Inaba K. Immunogenicity: role of dendritic cells. Bioessays 1989;10:145–52.
  • Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytesmigrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919–23.
  • Borras FE, Matthews NC, Lowdell MW, Navarrete CV. Identification of both myeloid CD11c + and lymphoid CD11c- dendritic cell subsets in cord blood. Br 7 Haematol 2001;113:925–31.
  • Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c- population. Blood 1999;93: 2302–7.
  • Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258–61.
  • Fraser JK, Cairo MS, Wagner EL et al. Cord Blood Transplanta-tion Study (COBLT): cord blood bank standard operating Procedures. 7 Hematother 1998;7:521–61.
  • Meehan KR, Arun B, Gehan EA et al. with interleukin-2 and alpha-interferon after IL-2- activated hematopoietic stem cell transplantation for breast cancer. Bone Marrow Transplant 1999;23:667–73.
  • Young JW, Szabolcs P, Moore MA. Identification of dendritic cellcolony-forming units among normal human CD34 + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/ macrophage colony-stimulating factor and rumor necrosis factor alpha [published erratum appears in J Exp Med 1995 Mar 1;183:1283]. yExp Med 1996;182: 1111–9.
  • Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of humancord blood dendritic cells: evidence for functional immaturity. Blood 1994;84:4333–43.
  • George-Chandy A, Mielcarek N, Nordstrom I et al. Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection. Infect Immun 2001;69:4120–4.
  • Liso A, Stockerl-Goldstein KE, Auffermann-Gretzinger S et al.Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2000;6:621–7.
  • Avigan D, Wu Z, Gong J et al. Selective in vivo mobilization withgranulocyte macrophage colony- stimulating factor (GM-CSF)/ granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplanta-tion. Clin Cancer Res 1999;5:2735–41.
  • Saraya K, Reid CD. Stem cell factor and the regulation of dendritic cell production from CD34 + progenitors in bone marrow and cord blood. Br y Haematol 1996;93:258–64.
  • Szabolcs P, Avigan D, Gezelter S et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 1996;87:4520–30.
  • Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilicalcord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Nail Acad Sci USA 1989;86:3828–32.
  • Caux C, Vanbervliet B, Massacrier C et al. CD34 + hemato-poietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNT alpha. y Exp Med 1996;184:695–706.
  • Zhang Y, Mukaida N, Wang J et al. Induction of dendritic celldifferentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit+ murine hematopoietic progenitor cells. Blood 1997;90:4842–53.
  • Strobl H, Bello-Fernandez C, Riedl E et a/. ligand in cooperationwith transforming growth factor-betal potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997;90:1425–34.
  • Strobl H, Riedl E, Scheinecker C et al. TGF-beta 1 dependentgeneration of LAG+ dendritic cells from CD34 + progenitors in serum-free medium. Adv Exp Med Biol 1997;417:161–5.
  • Luft T, Pang KC, Thomas E et al. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34 + progenitor cells. Exp Hematol 1998;26:489–500.
  • Domenech E, Villen E, Gonzalez-Barca E et al. Serum-free culture conditions for the generation of dendritic cells from cord blood CD34 + hematopoietic progenitors: phenotypic and functional analysis. Haematologica 2000;85:989–90.
  • Jaksits S, Kriehuber E, Charbonnier AS et al. CD34 + cell-derived CD14 + precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. yImmunol 1999;163:4869–77.
  • Sorg RV, Andres S, Kogler G et al. Phenotypic and functional comparison of monocytes from cord blood and granulocyte colony-stimulating factor-mobilized apheresis products. Exp Hematol 2001;29:1289–94.
  • Georgelas A, Schibler K. Characterization of myeloid and lymphoid subsets in dendritic cells derived from cord blood and adult blood. Exp Hematol 2000;28:1499.
  • Zheng Z, Takahashi M, Narita M et al. Generation of dendriticcells from adherent cells of cord blood by culture with granulocyte— macrophage colony-stimulating factor, interleu-kin-4, and tumor necrosis factor-alpha. 7 Hematother Stem Cell Res 2000;9:453–64.
  • Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived den-dritic cells in cord blood. Br 7 Haematol 2001;113: 240— 6.
  • Keever CA, Abu-Hajir M, Graf W et al. Characterization of thealloreactivity and anti-leukemia reactivity of cord blood mono-nuclear cells. Bone Marrow Transplant 1995;15:407— 19.
  • Goriely S, Vincart B, Stordeur P et al. Deficient IL-12(p35) geneexpression by dendritic cells derived from neonatal monocytes. Immunol 2001;166:2141–6.
  • Porcu P, Gaddy J, Broxmeyer HE. Alloantigen-induced un-responsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Neal Acad Sci USA 1998;95: 4538— 43.
  • Kurtzberg J, Martin P, Szabolcs P et al. Outcomes of unrelatedumbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank. Blood 2000;96(Suppl 1):206a.
  • Deeg HJ. Graft-versus-host disease: host and donor views. Semin Hematol 1993;30(Suppl 4):110–7.
  • Haridas V, Kamat RS. Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells. Clin Exp Immunol 1997;110:454–63.
  • Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graftversus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.